C9140 – Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9140
- Long description
- Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
- Short description
- Afstyla factor viii recomb
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- J7210
- Added
- January 1, 2017
- Last change
- January 1, 2018 – No change
- Termination date
- December 31, 2017
Frequently asked questions
What is HCPCS code C9140?
C9140 is a HCPCS Level II code for injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.. It was discontinued on December 31, 2017.
Does Medicare cover C9140?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9132 – Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- C9133 – Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
- C9134 – Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
- C9135 – Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
- C9136 – Injection, factor viii, fc fusion protein, (recombinant), per i.u.
- C9137 – Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
- C9138 – Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
- C9139 – Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
- C9141 – Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
- C9142 – Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
- C9143 – Cocaine hydrochloride nasal solution (numbrino), 1 mg
- C9144 – Injection, bupivacaine (posimir), 1 mg
- C9145 – Injection, aprepitant, (aponvie), 1 mg
- C9146 – Injection, mirvetuximab soravtansine-gynx, 1 mg
- C9147 – Injection, tremelimumab-actl, 1 mg
- C9148 – Injection, teclistamab-cqyv, 0.5 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.